Veritas Asset Management LLP reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,082,895 shares of the medical research company’s stock after selling 30,648 shares during the quarter. Bio-Rad Laboratories makes up […]